EPIC-Knee: Episealer® Knee System IDE Clinical Study is a prospective, randomised, controlled, multi-centre study to evaluate the safety and effectiveness of the Episealer® Knee System compared to microfracture for the treatment of focal femoral knee chondral or osteochondral lesions.

The study is performed at hospitals in the US, Canada, Germany, UK and Denmark and 180 patients are randomised at a 2:1 ratio to either the Episealer group (n=120) or the control group, microfracturing (n=60). All patients will be followed over a period of 2 years. The study is intended for patients in the age group 30-70 years with one single cartiladge lesion in the femoral knee joint.

Please select a country for more information about participating clinics:

More details about the EPIC-Knee study can be found at ClinicalTrials.gov (ID: NCT04000659).